Dr. Brandon DeKosky is an assistant professor of Chemical Engineering and Pharmaceutical Chemistry and affiliated with the Kansas Vaccine Institute at the University of Kansas, and his research emphasis is in high-throughput analyses of antibody immune responses. As a Ph.D. student at the University of Texas at Austin, Dr. DeKosky developed the very first technology for high-throughput sequencing complete antibody variable regions from single B cells, helping to resolve a major 20-year problem in immunology and biotechnology. As a postdoc at the U.S. National Institute of Allergy and Infectious Diseases, Dr. DeKosky applied high-throughput antibody sequencing and functional repertoire characterization to accelerate public health vaccine development. The DeKosky lab at KU now leverages high-throughput technologies to understand the critical features of adaptive immune protection and to develop novel strategies to combat human diseases. Dr. Brandon DeKosky is an assistant professor of Chemical Engineering and Pharmaceutical Chemistry and affiliated with the Kansas Vaccine Institute at the University of Kansas, and his research emphasis is in high-throughput analyses of antibody immune responses. As a Ph.D. student at the University of Texas at Austin, Dr. DeKosky developed the very first technology for high-throughput sequencing complete antibody variable regions from single B cells, helping to resolve a major 20-year problem in immunology and biotechnology. As a postdoc at the U.S. National Institute of Allergy and Infectious Diseases, Dr. DeKosky applied high-throughput antibody sequencing and functional repertoire characterization to accelerate public health vaccine development. The DeKosky lab at KU now leverages high-throughput technologies to understand the critical features of adaptive immune protection and to develop novel strategies to combat human diseases.

Vaccine, Immunology